CARER Group Named Finalist for Fierce Pharma's Innovative DEI Training and Education Award

The Fierce Pharma DEI Awards celebrate and recognize outstanding achievements in Diversity, Equity, and Inclusion (DEI) within the healthcare industry. This program honors organizations, initiatives, and individuals who are making significant strides in creating a more equitable and inclusive healthcare environment. Submissions were evaluated on innovation and impact, measurable outcomes, sustainability and scalability, and ethical considerations.

The Catalyzing Access to Research and Equity Representation (CARER Group) Group is made up of a group of Biotech professionals who have come together to draw awareness to the inequities that currently exist in the healthcare industry. They have developed the Clinical Trial Diversity (CTD) Score Card, a reporting and scoring system designed to evaluate diversity in the registrational clinical trials for novel drugs and biological products approved by US Food & Drug Administration (FDA). Since its launch in 2022, the CARER Group has scored every FDA approved drug.

Roivant Social Ventures was a founding member of the CARER Group.

View Clinical Trial Diversity Scorecards: https://carergroup.org/scorecards
Visit CARER's Website: https://carergroup.org/
Fierce Pharma DEI Awards Page: https://www.fiercediversityinclusion.com/fiercediversityinclusi/2024-dei-awards-winner